Skip to main content

GT Biopharma, Inc.

GTBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000109657

No open-market purchases or sales by GT Biopharma, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $1.02M in total; no superinvestor holds it.

Superinvestors holding GTBP, Q2 2026

See all superinvestors

No superinvestor reported holding GTBP in Q2 2026.